In Vitro Diagnostics (IVD): Laboratory Testing and Centralized vs. Distributed

In vitro diagnostics market reached $68.2B in 2024 with clinical chemistry and immunoassay representing 48% of testing volume. Centralized laboratory testing maintained dominance with 76% of clinical testing volume. Point-of-care and decentralized testing captured growth at 18% CAGR driven by COVID-era innovations and workflow improvements.

Drivers, Challenges & Trends

📈

Key Market Drivers

Market growth expected at strong CAGR through the forecast period, driven by rising demand, technology adoption, and expanding end-user applications globally.

⚠️

Growth Challenges

Complex regulatory landscapes, high R&D costs, supply chain constraints, and competitive intensity present challenges for market participants.

💡

Strategic Opportunities

Regional expansion, product innovation, strategic partnerships, and technology-enabled solutions offer significant growth potential for forward-looking companies.

What's Inside the Report

  • Executive Summary
  • IVD Market Overview
  • Testing Modalities
  • Centralized vs. Decentralized
  • Consolidation Trends
  • Reimbursement
  • Automation Impact
  • Future Outlook
  • Appendix
Free Preview

Sample Report Content

Get a glimpse of the comprehensive analysis included in this report.

Market Overview

In vitro diagnostics market reached $68.2B in 2024 with clinical chemistry and immunoassay representing 48% of testing volume. Centralized laboratory testing maintained dominance with 76% of clinical testing volume. Point-of-care and decentralized testing captured growth at 18% CAGR driven by COVID-era innovations and workflow improvements.

Detailed Segmentation Analysis

Comprehensive breakdown of market segments by type, application, and region with detailed growth projections through the forecast period.

Competitive Landscape Deep Dive

Strategic profiles of leading companies with SWOT analysis, financials, product portfolios, and recent developments across the competitive landscape.

Market Segmentation Breakdown

By Type

Segment A (Largest) Segment B Segment C Segment D Others

By Application

Application 1 (Leading) Application 2 Application 3 Application 4 (Fastest)

By Distribution Channel

Channel 1 Channel 2 Channel 3 (Fastest CAGR)

By Region

North America (Leading) Europe Asia-Pacific (Fastest) Latin America Middle East & Africa

Our Research Approach

IVD company tracking, 220 clinical lab director interviews, testing volume analysis, consolidation assessment

01
Secondary Research
Industry reports, filings & databases
02
Primary Research
Expert interviews & KOL surveys
03
Data Modelling
Statistical analysis & forecasting
04
Triangulation
Supply & demand-side validation

Data Sources

IVD Market Data Laboratory Reports Testing Volumes Regulatory Documents Financial Analysis

Companies Profiled

Strategic profiles of key players with SWOT analysis, financials, product portfolios, and recent developments included in this report.

IM
IVD Market Data
Profiled in Report
LR
Laboratory Reports
Profiled in Report
TV
Testing Volumes
Profiled in Report
RD
Regulatory Documents
Profiled in Report
FA
Financial Analysis
Profiled in Report

Questions This Report Answers

This report provides a comprehensive analysis of the In Vitro Diagnostics (IVD): Laboratory Testing and Centralized vs. Distributed covering market size, growth trends, competitive landscape, key players, segmentation, and regional analysis across 350 pages with detailed data tables and figures.
The report covers historical trends and provides forward-looking forecasts through the projected period.
The report is delivered in PDF + Excel format, including all data tables in editable spreadsheet form for your analysis needs. Delivery is instant upon purchase.
Yes, we offer 15% free customisation on all reports. You can tailor segments, geographies, competitor profiles, and specific data cuts to match your exact requirements. Contact our team to discuss.
The report profiles leading companies in the market with detailed SWOT analysis, financials, product portfolios, and recent strategic developments. Request a sample to see the full list of companies covered.
We employ a rigorous blend of primary research (expert interviews, industry surveys) and secondary research (financial filings, industry databases, peer-reviewed publications) validated through data triangulation.